CSIMarket
 
Bruker Corporation  (NASDAQ: BRKR)
 
Price: $61.3900 $-1.66 -2.633%
Day's High: $63.4900016784668 Week Perf: 16.58 %
Day's Low: $ 60.40 30 Day Perf: 4.67 %
Volume (M): 2,820,300 52 Wk High: $ 65.30
Volume (M$): $ 0 52 Wk Avg: $46.57
Open: $63.37 52 Wk Low: $30.09



 Market Capitalization (Millions $) 9,350
 Shares Outstanding (Millions) 152
 Employees 11,085
 Revenues (TTM) (Millions $) 3,499
 Net Income (TTM) (Millions $) -65
 Cash Flow (TTM) (Millions $) 41
 Capital Exp. (TTM) (Millions $) 97

Business Description


Bruker Corporation is a leading company in scientific instrumentation and solutions.
It provides high-performance scientific instruments and analytical solutions for various industries, including life science research, pharmaceuticals, biotechnology, food, and environmental testing.
The company was founded in 1960, and its headquarters are in Billerica, Massachusetts, USA.
Bruker Corporation has a wide range of products and services, including mass spectrometry, magnetic resonance imaging (MRI), microscopy and imaging, and X-ray analysis.
It also provides software and services that support the use of its instruments and analytical solutions.
Bruker Corporation is a global company with a strong presence in North Americas, Europe, Asia-Pacific, Middle East, and Africa.
The company has subsidiaries in more than 70 countries and employs around 8,200 people worldwide.
One of the strengths of Bruker Corporation is its focus on innovation and R&D.
The company invests heavily in R&D, and it has over 2,500 patents and patent applications.
Bruker Corporation has a track record of introducing groundbreaking products that have helped advance research and development in various industries.
In summary, Bruker Corporation is a leading company in scientific instrumentation and solutions with a wide range of products and services.
It operates globally and focuses on innovation and R&D.
Its products and services are used in various industries, including life science research, pharmaceuticals, biotechnology, food, and environmental testing.


   Company Address: 40 Manning Road Billerica 1821 MA
   Company Phone Number: 663-3660   Stock Exchange / Ticker: NASDAQ BRKR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
A        6.49% 
BIO        1.92% 
ILMN        16.07% 
MTD        7.64% 
RVTY        15.4% 
TXG        11.68% 
• View Complete Report
   



Business Update

Brukers Strategic Contracts and Market Resilience in a Tumultuous Landscape

Published Wed, Aug 6 2025 5:22 PM UTC

In a notable advancement for Bruker Corporation, the company has secured several multi-year contracts valued at over $27 million, specifically for its explosives and chemical trace detection solutions within the aviation and defense sectors. These agreements, finalized throughout 2025, represent a strategic initiative to bolster the capabilities of customers involved in avia...

Business Update

Brukers Balancing Act Groundbreaking Scientific Innovation Meets Financial Hurdles,

Published Fri, Apr 18 2025 12:25 PM UTC

Bruker Corporation Pushes Innovation Boundaries with nVista 2P, Faces Financial Challenges CSIMarket.com Bruker Corporation (Nasdaq: BRKR), a leader in scientific instrumentation, has unveiled its pioneering nVista 2P miniature two-photon microscope. Announced from San Jose, California, this state-of-the-art device represents a major advancement in the Inscopix product li...

Business Update

Bruker Deepens Diagnostic Expertise with Strategic Stake in Germanys RECIPE,

Published Wed, Apr 16 2025 10:48 AM UTC

In a strategic move to enhance its diagnostic capabilities, Bruker Corporation (NASDAQ: BRKR) has announced a majority investment in RECIPE Chemicals + Instruments GmbH. Based in Munich, Germany, RECIPE is a recognized leader in the production of mass spectrometry-based diagnostic assay kits, primarily geared towards therapeutic drug monitoring (TDM). A Strategic Fit By acqu...

Business Update

Bruker Corporations Mixed Quarter Strategic Advances Amidst ROI Challenges

Published Fri, Feb 21 2025 4:41 PM UTC

As the biotechnology landscape continues to evolve, Bruker Corporation finds itself at a crucial juncture. While the company gears up to showcase its groundbreaking advances at the upcoming AGBT 2025 conference, recent financial performance highlights a mixed bag of results. In the third quarter of 2024, Bruker reported a return on average invested assets (ROI) of 7.73%. Thi...

Business Update

Bruker Corporations Strategic Gains Amidst Industry Contractions An Analysis of Dimension Nexus and Market Performance

Published Mon, Dec 2 2024 2:47 PM UTC

As the scientific landscape continuously evolves, technological advancements hold the key to competitive differentiation. At the forefront of this evolution in the materials science sector is Bruker Corporation, a notable player in the atomic force microscopy (AFM) industry. At the 2024 MRS Fall Meeting & Exhibit, Bruker unveiled its latest product, the Dimension Nexus atomi...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.67
Price to Sales (Expected) -
Price to Book 3.9
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.18
Working Capital Ratio 1.84
Leverage Ratio (MRQ) 1.54
Total Debt to Equity 0.76
Interest Coverage (TTM) 43.08
Debt Coverage (TTM) 0.15

Per Share Current
Earnings (TTM) -0.61 $
Revenues (TTM) 22.97 $
Cash Flow (TTM) 0.27 $
Cash 1.43 $
Book Value 15.76 $
Dividend (TTM) 0.05 $

Efficiency Current
Revenue per Employee (TTM) 315,643
Net Income per Employee (TTM) -5,819
Receivable Turnover Ratio (TTM) 6.41
Inventory Turnover Ratio (TTM) 1.65
Asset Turnover Ratio (TTM) 0.52

Profitability Ratios Current
Gross Margin (MRQ) 49.61 %
Operating Margin (MRQ) -7.79 %
Net Margin (MRQ) -6.07 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield 0.08 %
Pay out Ratio (TTM) -



Bruker's Segments
Product    156.24 % of total Revenue
Product and Service Other    41.96 % of total Revenue
US    56.06 % of total Revenue
DE    15.16 % of total Revenue
Europe excluding Germany    60.01 % of total Revenue
CN    21.34 % of total Revenue
Asia Pacific excluding China    29.47 % of total Revenue
Other Country    16.16 % of total Revenue
BSI BioSpin    46.89 % of total Revenue
BSI CALID    74.73 % of total Revenue
BSI Nano    60.5 % of total Revenue
Energy and Supercon Technologies    16.82 % of total Revenue
Intersegment Elimination    0.74 % of total Revenue
Member    198.94 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.